Company Filing History:
Years Active: 2017
Title: Innovations of Jae Keun Yu in Liquid Formulations
Introduction
Jae Keun Yu is a notable inventor based in South Korea, recognized for his contributions to the field of biopharmaceuticals. His work primarily focuses on the development of liquid formulations that enhance the stability and efficacy of therapeutic proteins.
Latest Patents
Jae Keun Yu has developed a significant patent titled "A Liquid Formulation Of A Fusion Protein Comprising Tnfr And Fc Region." This patent discloses a liquid formulation that includes a TNFR-Fc fusion protein and a stabilizer. The formulation is designed to provide excellent storage stability, allowing for long-term storage of the TNFR-Fc fusion protein, commonly known as etanercept. The formulation is economical and does not require specific storage conditions, making it advantageous for therapeutic applications.
Career Highlights
Jae Keun Yu is currently associated with Ares Trading S.A., where he continues to innovate in the field of liquid formulations. His work has the potential to significantly impact the treatment of various conditions that benefit from TNFR-Fc fusion proteins.
Collaborations
Jae Keun Yu collaborates with esteemed colleagues, including Jung Tae Lee and In Hyuk Kim, to further advance his research and development efforts.
Conclusion
Jae Keun Yu's innovative work in liquid formulations represents a significant advancement in biopharmaceuticals, particularly in enhancing the stability and usability of therapeutic proteins. His contributions are poised to make a lasting impact in the medical field.